Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 2
2008 2
2009 1
2010 1
2011 1
2012 3
2014 1
2015 1
2016 3
2018 1
2019 2
2020 16
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

37 results
Results by year
Filters applied: . Clear all
Page 1
Cholangiocarcinoma: Epidemiology and risk factors.
Khan SA, Tavolari S, Brandi G. Khan SA, et al. Among authors: tavolari s. Liver Int. 2019 May;39 Suppl 1:19-31. doi: 10.1111/liv.14095. Epub 2019 Mar 24. Liver Int. 2019. PMID: 30851228 Review.
Asbestos and Intrahepatic Cholangiocarcinoma.
Brandi G, Tavolari S. Brandi G, et al. Among authors: tavolari s. Cells. 2020 Feb 12;9(2):421. doi: 10.3390/cells9020421. Cells. 2020. PMID: 32059499 Free PMC article. Review.
Evolution of the Experimental Models of Cholangiocarcinoma.
Massa A, Varamo C, Vita F, Tavolari S, Peraldo-Neia C, Brandi G, Rizzo A, Cavalloni G, Aglietta M. Massa A, et al. Among authors: tavolari s. Cancers (Basel). 2020 Aug 17;12(8):2308. doi: 10.3390/cancers12082308. Cancers (Basel). 2020. PMID: 32824407 Free PMC article. Review.
In Reply.
Brandi G, Deserti M, Vasuri F, Farioli A, Degiovanni A, Palloni A, Frega G, Barbera MA, de Lorenzo S, Garajova I, Di Marco M, Pinna AD, Cescon M, Cucchetti A, Ercolani G, D'Errico-Grigioni A, Pantaleo MA, Biasco G, Tavolari S. Brandi G, et al. Among authors: tavolari s. Oncologist. 2016 Dec;21(12):e5-e6. doi: 10.1634/theoncologist.2016-0286. Epub 2016 Nov 2. Oncologist. 2016. PMID: 27807301 Free PMC article.
Nivolumab: an investigational agent for the treatment of biliary tract cancer.
Di Federico A, Rizzo A, Ricci AD, Frega G, Palloni A, Tavolari S, Brandi G. Di Federico A, et al. Among authors: tavolari s. Expert Opin Investig Drugs. 2021 Apr;30(4):325-332. doi: 10.1080/13543784.2021.1863946. Epub 2020 Dec 23. Expert Opin Investig Drugs. 2021. PMID: 33307866 Review.
Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow.
Rizzo A, Ricci AD, Tober N, Nigro MC, Mosca M, Palloni A, Abbati F, Frega G, DE Lorenzo S, Tavolari S, Brandi G. Rizzo A, et al. Among authors: tavolari s. Anticancer Res. 2020 Jun;40(6):3013-3030. doi: 10.21873/anticanres.14282. Anticancer Res. 2020. PMID: 32487595 Review.
Current and novel therapeutic opportunities for systemic therapy in biliary cancer.
Marin JJG, Prete MG, Lamarca A, Tavolari S, Landa-Magdalena A, Brandi G, Segatto O, Vogel A, Macias RIR, Rodrigues PM, Casta A, Mertens J, Rodrigues CMP, Fernandez-Barrena MG, Da Silva Ruivo A, Marzioni M, Mentrasti G, Acedo P, Munoz-Garrido P, Cardinale V, Banales JM, Valle JW, Bridgewater J, Braconi C; working group 6 of the COST-action 18122 (Euro-Cholangio-NET) as part of the European Network for the study of Cholangiocarcinoma (ENSCCA). Marin JJG, et al. Among authors: tavolari s. Br J Cancer. 2020 Sep;123(7):1047-1059. doi: 10.1038/s41416-020-0987-3. Epub 2020 Jul 22. Br J Cancer. 2020. PMID: 32694694 Free PMC article. Review.
37 results